Newsroom | 30112 results

SAN FRANCISCO--(BUSINESS WIRE)--Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on selective cellular rejuvenation medicines targeting aging cells, today announced preliminary results from a Phase 1b/2a study of RLS-1496 in patients with actinic keratosis (AK), a common age-related condition resulting in precancerous skin lesions, that is most commonly seen after age 65.1 The open-label multi-center trial, conducted in the United States, assessed the safety, to...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Holdings, Inc. (Nasdaq: HIND)(“Vyome”), a clinical-stage biopharmaceutical company focused on immuno-inflammatory and rare disease conditions, today reports financial results for the first quarter ended March 31, 2026, and provides a corporate update. Krishna Gupta, Chairman of Vyome, said, “Over the last several quarters, Vyome has executed with focus and discipline, advancing differentiated programs in areas of significant unmet medical need focused on...

MIAMI--(BUSINESS WIRE)--The National Applied AI Consortium expands its mission into high schools with a $299,990 grant from the National Science Foundation....

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the Thermo Scientific™ Orbitrap™ Tribrid™ Apex and Thermo Scientific™ Orbitrap™ Excedion™ mass spectrometers will be showcased at the American Society for Mass Spectrometry (ASMS) Conference. As scientific discovery expands into more complex applications—from advanced proteomics and multiomics to biologics and genetic medicines—researchers and drug developers face inc...

NEW YORK--(BUSINESS WIRE)--Real Chemistry announced the appointments of two non-executive board members, Frank Clyburn and Christopher Fikry, M.D....

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma announces patent applications and preclinical data supporting investigational intranasal and pulmonary GLP-1 delivery....

PITTSBURGH--(BUSINESS WIRE)--Life Science Connect ( “LSC”) is pleased to announce the appointment of Tony Cannon as its Chief Financial Officer. LSC welcomes Mr. Cannon to the team at a pivotal moment as the Company continues to strengthen its financial infrastructure and capabilities to support its continued growth. LSC is a portfolio company of Latticework Capital Management and Edgehill Management. LSC, headquartered in Pittsburgh, Pennsylvania, operates a network of trusted editorial commun...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the election of Kathleen Tregoning to its Board of Directors at the annual general meeting of shareholders. Ms. Tregoning is expected to serve on the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee. She brings extensive experience guiding bio...

LILLE, France--(BUSINESS WIRE)--Alzprotect today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for AZP2006 (Ezeprogind®) for the treatment of Progressive Supranuclear Palsy (PSP). FDA clearance permits the Company to begin clinical development of AZP2006 in the United States. “FDA IND clearance is a pivotal step in our PSP program,” said Philippe Verwaerde, PhD, President & Chief science Officer. “We can now e...

OTTAWA, Ontario--(BUSINESS WIRE)--BioTalent Canada is advancing their development of a cleanroom readiness certification for the health and bioscience sector, supported by a digital twin cleanroom training environment designed to simulate cleanroom scenarios for scalable learning and practice. As Canada’s bio-economy evolves rapidly across biomanufacturing, clean technologies, and health sciences, the certification and digital twin cleanroom training will provide employers and training partners...